Proteintech Group: For Scientists, By Scientists
Proteintech Group was founded in 2001 by a group of scientists, who were actively engaged in NIH funded research at the time. One of the original founders and current CEO Dr. Jason Li was an Associate Professor of Immunology at the University of Illinois at Chicago during the company's foundation years. He says of the reasons behind Proteintech's establishment:
"AT THE HEART OF OUR ASPIRATION WAS A COMPANY FOR SCIENTISTS BY SCIENTISTS; AN ANTIBODY PROVIDER THAT WOULD OFFER RESEARCHERS THE ADVANTAGE — NOT INVESTORS."
As a company founded by scientists, Proteintech Group recognises the tireless efforts and sacrifices made by researchers to advance scientific discovery. Proteintech aims to match its’ customers’ dedication to research by providing high quality, reliable reagents that contribute to reproducible results.
3
Awards
400,000+
Product Citations
8
Offices
Proteintech Group Milestones
Proteintech launches “Able” AI – A first-of-its-kind tool.
Launch of the Blotting Accelerator, shortening the WB protocol to 40mins.
Proteintech unveils next-gen 3D epitope mapping validation
Speedy One-Step ELISA kits are launched, enabling analyte detection in 90 mins or less
Launch of our FC-zero product range
First matched antibody pair is launched.
Proteintech expands in China with two brand-new buildings located in the Wuhan East Lake High-tech Development Zone and Shanghai.
Proteintech Europe expands with a new office and a training laboratory in Manchester, UK.
Proteintech launches its FlexAble antibody labelling product range.
Proteintech establishes a new subsidary, Proteintech Genomics in San Diego, CA. Proteintech Genomics develop fully optimized and highly multiplexed proteomic assays.
Proteintech opens new Singapore office
Proteintech acquires ChromoTek, the market leader in nanobodies.
Proteintech’s HumanKine® cytokines and growth factors now available in GMP-compliant versions for use in clinical trials and commercial manufacturing.
Launch of 500+ antibodies directly conjugated with high-performance CoraLite®488, CoraLite®594 and CoraLite®647 dyes.
Proteintech product features in a publication for the 5,000th time.
First ELISA kit goes on sale.
Proteintech features in a publication for the 1,000th time (Nature Cell Biology).
ChromoTek launches GFP-trap, the first Nanobody-based reagent for IP.
Foundation of ChromoTek GmbH in Munich, Germany.
Proteintech product features in a publication for the 100th time (Zhang et al, Blood).
Proteintech Europe Ltd opens in Manchester, UK.
First mouse monoclonal antibody goes on sale.
Chinese office opens in Wuhan, China.
First publication with a pre-made antibody (Recoverin antibody – 10073-1-AP, Kicic et al. Journal of Neuroscience)
Proteintech Group is founded.
Scientist Success Stories
With 350,000 citations worldwide, Proteintech products have played a part in groundbreaking research globally for over two decades. Read some of our success stories from our customers below: